Loading...
XSHG
600511
Market cap2.96bUSD
Oct 09, Last price  
26.67CNY
1D
1.45%
1Q
-0.71%
Jan 2017
-11.40%
IPO
916.41%
Name

China National Medicines Corporation Ltd

Chart & performance

D1W1MN
XSHG:600511 chart
P/E
10.08
P/S
0.38
EPS
2.65
Div yield, %
3.04%
Shrs. gr., 5y
—
Rev. gr., 5y
5.38%
Revenues
52.47b
+3.70%
2,807,039,7153,573,788,0104,385,472,4695,194,599,5355,918,037,6147,042,245,9418,591,632,46210,081,474,20511,538,342,52112,078,194,12334,610,563,02036,284,746,32838,739,827,10444,644,476,40440,378,608,10746,468,602,84445,498,583,76349,696,045,52850,597,449,78852,468,280,576
Net income
2.00b
-0.18%
83,475,080131,102,366193,825,940226,599,176261,116,656271,261,168335,815,813411,509,717482,653,724512,845,022990,187,0171,141,484,9531,404,095,4081,603,898,6931,382,688,4421,754,084,2251,964,057,5622,145,998,7502,000,126,9501,996,593,114
CFO
2.04b
+22.82%
121,497,89979,475,727217,095,150255,178,000318,212,8510185,868,315185,563,414218,943,203440,285,456591,250,4271,074,491,395981,654,0681,776,070,4911,301,671,1041,957,451,0322,395,123,4542,726,657,0971,659,119,5232,037,791,398
Dividend
Jun 18, 20260.8 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.

Key people

Chairman of the Board · since 2017
Hui Li
General Manager, Director · since 2018
Renli Jin
Deputy General Manager · since 2019
Wei Shao
Deputy General Manager · since 2012
Jie Wu
Deputy General Manager · since 2014
Zhiming Li
Director · since 2018
Yong Liu
Director · since 2017
Director · since 2019
Independent Director · since 2015
IPO date
Nov 27, 2002
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
北京市东城区永外三元西巷甲12号
东城区, BJ 100000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT